Ignite Creation Date:
2025-12-24 @ 11:15 PM
Ignite Modification Date:
2026-01-18 @ 1:45 PM
Study NCT ID:
NCT02567656
Status:
COMPLETED
Last Update Posted:
2020-01-13
First Post:
2015-09-03
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety and Efficacy Study of a Dual PI3K Delta/Gamma Inhibitor in T-cell Lymphoma
Sponsor:
Rhizen Pharmaceuticals SA
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
RP6530-1401
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None